| Pharmaceutical active ingredients: |
| Cytarabine |
| Available forms, composition and doses of DepoCyte: |
| Injectable; Injection; Cytarabine 50 mg |
| DepoCyte medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01BC01 - Cytarabine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Napp PharmaceuticalsMundipharmaNorpharmaSkyePharma |
| Related documents and information about DepoCyte: |
| DepoCyte prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Betasept | Povidone-Iodine | Napp Pharmaceuticals |
| Bradilan | Nicofuranose | Napp Pharmaceuticals; Mundipharma |
| BuTrans | Buprenorphine | Napp Pharmaceuticals; LTC Lohmann Therapiesysteme; Purdue Pharma |
| Co-danthramer | Dantron; Poloxamer | Napp Pharmaceuticals |
| Codella | Glycerol; Kaolin; Povidone-Iodine | Napp Pharmaceuticals |
| Flexin Continus | Indometacin | Napp Pharmaceuticals; Mundipharma |
| Gastrobid | Metoclopramide Hydrochloride | Napp Pharmaceuticals; Mundipharma |
| Gastrobid Continus | Metoclopramide Hydrochloride | Napp Pharmaceuticals; Mundipharma |
| Imazin | Aspirin; Isosorbide Mononitrate | Napp Pharmaceuticals |
| Morsep | Cetrimide; Vitamin A (Vitamin A Palmitate); Vitamin D2 (Ergocalciferol) | Napp Pharmaceuticals; Mundipharma |